Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.60 |
| ▸ | ESR1 | P03372 | 5/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.52 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.52 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15663072 | 0.98 | EPHX1 (0.58) | EPHX1ESR1ESR2PDCD1CD274 | |
| SCHEMBL455795 | 0.89 | EPHX1 (0.50) | EPHX1ESR1ESR2PDCD1CD274 | |
| SCHEMBL3054675 | 0.82 | EPHX1 (0.60) | EPHX1SMN1; SMN2APPLMNACYP2C19 | |
| SCHEMBL964721 | 0.82 | EPHX1 (0.60) | EPHX1ESR1GAAAPPLMNA | |
| SCHEMBL13446952 | 0.82 | EPHX1 (0.60) | EPHX1ESR1GAAAPPLMNA | |
| SCHEMBL3261236 | 0.82 | EPHX1 (0.60) | EPHX1ESR1GAAAPPLMNA | |
| SCHEMBL16750533 | 0.82 | EPHX1 (0.60) | EPHX1SMN1; SMN2APPLMNACYP2C19 | |
| SCHEMBL11749792 | 0.81 | ESR1 (0.56) | ESR1ESR2PDCD1CD274MAPT | |
| SCHEMBL7794207 | 0.80 | EPHX1 (0.58) | EPHX1APPCYP3A4LMNACYP1A2 | |
| SCHEMBL2055564 | 0.80 | EPHX1 (0.58) | EPHX1APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108387652-B | Method for detecting impurities in compound paracetamol diphenhydramine tablets | 四川省食品药品检验检测院 | 2021-03-02 | — | — | CN | claimed |
| CN-104030941-A | Synthesis method of 3-(4-hydroxyphenyl)propanamide | UNIV CHANGZHOU | 2014-09-10 | — | — | CN | claimed |
| CN-101336227-A | Nuclear receptor binding agents | GTX INC (US) | 2008-12-31 | — | — | CN | claimed |
| CN-101296698-A | Combination of compounds for the treatment of respiratory diseases, in particular Chronic Obstructive Pulmonary Disease (COPD) and asthma | ASTRAZENECA AB (SE) | 2008-10-29 | — | — | CN | claimed |
| CN-101296701-A | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma | ASTRAZENECA AB (SE) | 2008-10-29 | — | — | CN | claimed |
| EP-1565446-A1 | CHK-, PDK- AND AKT-INHIBITORY PYRIMIDINES, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-08-24 | — | — | EP | claimed |
| WO-2004048343-A1 | CHK-, PDK- AND AKT-INHIBITORY PYRIMIDINES, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-06-10 | — | — | WO | claimed |
| WO-2025038820-A1 | NYLON COMPOSITIONS | SCI-LUME LABS, INC. (US) | 2025-02-20 | — | — | WO | disclosed |
| WO-2023226965-A1 | ROCK INHIBITORS AND USES THEREOF | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) | 2023-11-30 | — | — | WO | disclosed |
| CN-116144153-A | Functional master batch and preparation method and application thereof | 山东睿安新材料科技有限公司 | 2023-05-23 | — | — | CN | disclosed |
| WO-2023044590-A1 | POLYMERIC BATCH TO PREPARE AN ANTIMICROBIAL MATERIAL AND AIR FILTER | IMPORTADORA Y EXPORTADORA JCN LIMITADA (CL) | 2023-03-30 | — | — | WO | disclosed |
| CN-114671863-A | Deuterated sufentanil derivative and pharmaceutical composition containing same | 三峡大学 | 2022-06-28 | — | — | CN | disclosed |
| CN-108387652-B | Method for detecting impurities in compound paracetamol diphenhydramine tablets | 四川省食品药品检验检测院 | 2021-03-02 | — | — | CN | disclosed |
| US-5252252-A | Longitudinal polarization | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1993-10-12 | — | — | US | disclosed |
| US-5120467-A | Longitudinal polarization and-or cross-polarization | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1992-06-09 | — | — | US | disclosed |
| US-4863903-A | RENIN ENZYME INHIBITORS, HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
| US-4723005-A | CONTAINING POLARIZED CYANO OR HALOGEN SUBSTITUENTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-02-02 | — | — | US | disclosed |
| US-4719288-A | HYPOTENSIVE | CIBA-GEIGY CORPORATION (US) | 1988-01-12 | — | — | US | disclosed |
| EP-0139996-B1 | ANISOTROPIC COMPOUNDS AND LIQUID CRYSTAL MIXTURES | MERCK PATENT GmbH (DE) | 1987-11-04 | — | — | EP | disclosed |
| US-4613676-A | PEPTIDES | CIBA-GEIGY CORPORATION (US) | 1986-09-23 | — | — | US | disclosed |